+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Substance Abuse Treatment Market 2020-2026

  • ID: 5148115
  • Report
  • July 2020
  • Region: Global
  • Orion Market Research Private Limited
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Alkermes PLC
  • BioCorRx, Inc.
  • Bristol Myers Squibb Co.
  • Indivior PLC
  • Mallinckrodt PLC
  • Novartis AG (Sandoz)
  • MORE
Global Substance Abuse Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Drug Abuse Treatment, Nicotine Addiction Treatment, and Alcohol Addiction Treatment), By Distribution Channel (Retail, Rehabilitation Center) Forecast Period 2020-2026.

The global substance abuse treatment market is anticipated to grow at a CAGR 10.5% during the forecast period. Substance abuse is referred to the use of psychoactive substances such as alcohol and various other illicit drugs. Substance abuse can lead to significant impairment or distress which is harmful to the person’s health. Factor such as the increasing trend of tobacco use in its all form is significantly driving the substance abuse treatment market. According to the World Health Organization, nearly 8 million mortalities are registered each year all across the globe due to tobacco use, out of which more than 7 million mortalities are the result of direct tobacco use.

The global substance abuse treatment market is segmented based on the treatment type and distribution channel. Based on the treatment type, the market is sub-segmented into drug abuse treatment, nicotine addiction treatment, and alcohol addiction treatment. Drug abuse treatment is expected to hold a major market share during the forecast period. By distribution channel, the market is segmented into retail and rehabilitation center.

The global substance abuse treatment market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to hold a major market share during the forecast period whereas Asia-Pacific will witness a subsequent increase in demand for substance abuse treatment in the near future.

The key players of the global substance abuse treatment market include Amphastar Pharmaceuticals, Inc., Adial Pharmaceuticals, BioCorRx, Inc., Purdue Pharma L.P., Sun Pharmaceutical Industries Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including merger & acquisition, collaborations with government, new drug launches, and various other advancements to stay competitive in the market.

Research Methodology:

The market study of the global substance abuse treatment market is incorporated by extensive primary and secondary research. Secondary research has been conducted to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.
The report is intended for the drug manufacturers, hospitals & clinics, government, rehabilitation centers, online pharmacy companies, and other related industries for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products offered by the companies, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation:

1. Global Substance Abuse Treatment Market Research and Analysis by Treatment Type
2. Global Substance Abuse Treatment Market Research and Analysis by Distribution Channel

The Report Covers:
  • Comprehensive research methodology of the global substance abuse treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global substance abuse treatment market.
  • Insights about market determinants which are stimulating the global substance abuse treatment market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Alkermes PLC
  • BioCorRx, Inc.
  • Bristol Myers Squibb Co.
  • Indivior PLC
  • Mallinckrodt PLC
  • Novartis AG (Sandoz)
  • MORE
1. Report Summary
1.1. Research Business Functions and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Amphastar Pharmaceuticals, Inc.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Alkermes PLC
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Pfizer Inc.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Purdue Pharma L.P.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Alkermes plc
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments

4. Market Determinants
4.1 Motivators
4.2 Restraints
4.1. Opportunities

5. Market Segmentation
5.1. Global Substance Abuse Treatment Market by Treatment Type
5.1.1. Drug Abuse Treatment
5.1.1.1. Methadone
5.1.1.2. Buprenorphine
5.1.1.3. Naltrexone
5.1.1.4. Other
5.1.2. Nicotine Addiction Treatment
5.1.2.1. NRT Therapy
5.1.2.2. Varenicline
5.1.2.3. Bupropion
5.1.2.4. Other
5.1.3. Alcohol Addiction Treatment
5.1.3.1. Acamprosate
5.1.3.2. Disulfiram
5.1.3.3. Naltrexone
5.1.3.4. Benzodiazepines
5.1.3.5. Other
5.2. Global Substance Abuse Treatment Market by Distribution Channel
5.2.1. Retail
5.2.2. Rehabilitation Center

6. Regional Analysis
6.1. North America
6.1.1. US
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Adial Pharmaceuticals Inc.
7.2. Alkermes PLC
7.3. Allergan plc (Subsidiary of AbbVie)
7.4. Amphastar Pharmaceuticals, Inc.
7.5. BioCorRx, Inc.
7.6. Bristol Myers Squibb Co.
7.7. Indivior PLC
7.8. Mallinckrodt PLC
7.9. Novartis AG (Sandoz)
7.10. Opiant Pharmaceuticals Inc.
7.11. Pfizer Inc.
7.12. Purdue Pharma L.P.
7.13. Reckitt Benckiser Group plc
7.14. Sun Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
3 of 3
  • Adial Pharmaceuticals Inc.
  • Alkermes PLC
  • Allergan plc (Subsidiary of AbbVie)
  • Amphastar Pharmaceuticals, Inc.
  • BioCorRx, Inc.
  • Bristol Myers Squibb Co.
  • Indivior PLC
  • Mallinckrodt PLC
  • Novartis AG (Sandoz)
  • Opiant Pharmaceuticals Inc.
  • Pfizer Inc.
  • Purdue Pharma L.P.
  • Reckitt Benckiser Group plc
  • Sun Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll